Prostate Cancer
Degarelix Acetate Prior to Radiation Therapy (7846)
Degarelix Acetate Prior to Radiation Therapy
Investigator: Robert Bruce Montgomery, MD; Conditions: Prostate Cancer; Status: Recruiting; Study ID: NCT01731912
An Open-Label, Phase 1/2, Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 in Patients With Progressive Advanced Castration-Resistant Prostate Cancer
Investigator: Celestia S. Higano, MD; Conditions: Prostate Cancer; Status: Recruiting; Study ID: NCT01171898
Canary Prostate Active Surveillance Study
Investigator: Daniel W. Lin, MD; Conditions: Prostatic Neoplasms; Status: Recruiting; Study ID: NCT00756665
A Randomized Phase II Study of Intermittent Chemotherapy or Intermittent Chemotherapy with Maintenance GM-CSF in Patients with Previously Untreated Metastatic Hormone Refractory Prostate Cancer
Investigator: Tia Higano, MD; Conditions: Prostate Cancer; Status: Recruiting; Study ID: NCT00488982
Phase 2 Trial of Radiation with Androgen Deprivation (RAD): Abiraterone Acetate, Prednisone and LHRH Agonist Prior to and Concurrent with Radiation Therapy.
Investigator: Robert Montgomery, MD; Conditions: Prostate Cancer, Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer, Stage IV Prostate Cancer; Status: Recruiting; Study ID: NCT01023061
Join Us On